Raiffeisen Bank International AG (0NXR)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 56.23 |
|---|---|
| 52-week range | 29.56 – 66.85 |
| Return, 1 month / 3 months | −12.5% / +0.8% |
| Return, 1 year / 3 years | +95.3% / +401.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 38.9% |
| Worst drawdown (1 year) | -19.6% |
| Average daily value traded | 1.26M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Raiffeisen Bank International is an Austrian banking group based in Vienna. It provides retail and corporate banking, investment banking and leasing services through subsidiary banks in Central and Eastern Europe, serving private customers, small and medium-sized businesses and large corporate clients. Its activities include deposit taking, lending, payment services and treasury operations across its regional network.
Raiffeisen Bank International AG trades under the code 0NXR on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Raiffeisen Bank International AG (0NXR) trades on the London Stock Exchange in UK. It last closed at EUR 56.23 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 805 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 95.3% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.5% | ||
| From 52-week high | -15.3% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | 28.5% | ||
| 12-month return, skipping the last month | 123.3% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.6% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.26M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −12.5% |
| 3 months | +0.8% |
| 6 months | +28.5% |
| 1 year | +95.3% |
| 3 years | +401.2% |
| 5 years | +200.5% |
Signals
| 50-day / 200-day average | 60.84 / 49.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Apr 2026 | EUR 1.6000 |
| 31 Mar 2025 | EUR 1.1000 |
| 9 Apr 2024 | EUR 1.2500 |
| 24 Nov 2023 | EUR 0.8000 |
| 31 Mar 2023 | EUR 0.8000 |
| 15 Nov 2021 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.